首页 › 基金 › Ikarian Capital, LLC › CTNM
Ikarian Capital, LLC 对 CTNM 的持仓历史
CONTINEUM THERAPEUTICS INC · 医疗保健
Ikarian Capital, LLC 在 Q3 2026 的 13F 申报中披露持有 CTNM(CONTINEUM THERAPEUTICS INC)300,000 股,市值约 US$4.0M,约占其申报组合的 0.59%,在其申报持仓中市值排名第 45 位。 Ikarian Capital, LLC 最近 4 个申报季度中有 4 个季度披露了 CTNM 持仓,最早可追溯至 Q4 2025。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Ikarian Capital, LLC 对 CTNM 的持仓演变
Ikarian Capital, LLC 于 Q4 2025 首次披露 CTNM 持仓:282,874 股(约 US$3.2M)。 该持仓在 Q2 2026 达到峰值 807,874 股,市值约 US$13.2M。 在 4 次申报中,Ikarian Capital, LLC 1 次增持、1 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 300,000 股、市值约 US$4.0M,环比减持 -507,874 股。。 持仓曾出现大幅变动:Q1 2026 增持约 186% (随后一个季度股价上涨 25%)、Q3 2026 减持约 63% (随后一个季度股价下跌 28%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2025 | 282.87K | $3.23M | 新进 |
| Q1 2026 | 807.87K | $10.55M | 增持 |
| Q2 2026 | 807.87K | $13.24M | 持有 |
| Q3 2026 | 300.00K | $4.03M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 CTNM 与 13F 数据
CTNM(CONTINEUM THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 54 只申报持有 CTNM,申报仓位最大的包括:MONTANOVA CAPITAL, LLC (US$37.8M), JOHNSON & JOHNSON (US$26.6M), Trails Edge Capital Partners, LP (US$22.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 CTNM 的基金
- MONTANOVA CAPITAL, LLC 2.81M 股 · $37.77M · Q3 2026
- JOHNSON & JOHNSON 1.98M 股 · $26.56M · Q3 2026
- Trails Edge Capital Partners, LP 1.69M 股 · $22.73M · Q3 2026
- Versant Venture Management, LLC 1.29M 股 · $17.35M · Q3 2026
- Novo Holdings A/S 704.01K 股 · $9.45M · Q3 2026
- SECTORAL ASSET MANAGEMENT INC 689.59K 股 · $9.25M · Q3 2026
- 高瓴资本 669.34K 股 · $8.98M · Q3 2026
- Red Tree Management, LLC 638.16K 股 · $8.56M · Q3 2026
- Boxer Capital Management, LLC 494.00K 股 · $6.63M · Q3 2026
- Squadron Capital Management LLC 225.00K 股 · $3.02M · Q3 2026
- Palo Alto Investors LP 220.23K 股 · $2.96M · Q3 2026
- HighVista Strategies LLC 217.79K 股 · $2.92M · Q3 2026
更多关于 Ikarian Capital, LLC
常见问题
How long has Ikarian Capital, LLC held CTNM?
Ikarian Capital, LLC has disclosed CTNM holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Ikarian Capital, LLC's current position in CTNM?
As of Q3 2026, Ikarian Capital, LLC holds 300.00K shares of CTNM (CONTINEUM THERAPEUTICS INC), valued at $4.03M, representing 0.59% of its reported portfolio and ranking #45.
Has Ikarian Capital, LLC been buying or selling CTNM?
In the latest 13F filing (Q3 2026), Ikarian Capital, LLC reduced its position in CTNM. The position peaked in Q2 2026 at 807.87K shares.
Which other funds hold CTNM?
Other major institutional holders of CTNM include MONTANOVA CAPITAL, LLC, JOHNSON & JOHNSON, Trails Edge Capital Partners, LP, among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.